Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Regent Lee at the Nuffield Department of Surgical Sciences (NDS) who has been awarded a grant of £246,226 from Heart Research UK for his research project ‘Using artificial intelligence (AI) for safer CT imaging of blood vessels’.

CT without contrast dye (Figure A) and CT with contrast dye (Figure B)

Computerised tomography (CT or CAT) scans are widely used in all fields of medicine and surgery. Where treatment of a blood vessel is being considered, doctors need a detailed view inside the blood vessel. For example, blood clots are often found inside arteries or veins. The position and shape of the clot, in relation to the blood vessel wall is important for the planning of treatment such as the placement of a stent. 

On routine CT scans, the human eye cannot detect the presence abnormalities inside the blood vessel. An example is the presence of blood clot (Figure A, white arrows point towards the blood vessel). To make it clearer, a special dye, called a contrast agent, is injected into the patient. This makes it easier to visualise the blood flowing through the blood vessel and the blood clot (Figure B). These are called ‘contrast enhanced’ CT scans.

There are several problems with the use of contrast dye. Contrast enhanced CT scans take longer to complete and requires more radiation exposure to the patient. Patients usually get some mild reactions to the contrast dye and may be allergic to it (in which case they cannot have contrast enhance CT scans). Importantly, the use of contrast dye requires the insertion of a needle into the patient’s arm. This is uncomfortable can result in problems such as contrast dye leakage outside the injection site and cause skin problems.  Contrast dye can sometimes damage the kidneys, which is called ‘contrast induced nephropathy’. This can be a particular problem in elderly patients whose kidneys are not working at full capacity. 

Although human eyes cannot tell the difference between blood flow and clot within the blood vessel on a routine CT scan, there are minute details in the scan that can be used to differentiate them. Dr Lee and his team has developed a technology to generate contrast enhanced CT scans without the need to inject contrast dye. HRUK will support Dr Lee’s team to further develop their technology through the Novel and Emerging Technology Award.

If successful, this research will allow diagnosis and treatment of blood vessel conditions with a reduced risk of complications. The reduced scanning time, radiation dose and lower cost would bring important benefits. Furthermore, the method can be extended for diagnosis and treatment planning for other medical conditions where contrast enhanced CT scanning is required. 

'I am grateful for the generous support by Heart Research UK', said Dr Lee. 'Credit goes to our brilliant DPhil student, Anirudh Chandrashekar, for generating the pilot data, and the co-Investigators, Professor Ashok Handa and Professor Vicente Grau Colomer.'

 

 

Similar stories

Clare Verrill receives Turing Fellowship

Thirty-three University of Oxford researchers have been named Turing Fellows for the 2021/22 academic year, including Associate Professor Clare Verrill from the Nuffield Department of Surgical Sciences (NDS).

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

Jonathan Meakins to be inducted into Canadian Medical Hall of Fame

Professor Jonathan L. Meakins, who was Head of the Nuffield Department of Surgery from 2002 to 2008, has been selected for induction into the Canadian Medical Hall of Fame.

Discovered gene patterns can predict prostate cancer treatment response

Nearly 40,000 men are diagnosed with prostate cancer each year in the UK. Perhaps the most significant clinical challenge today is deciding which type of treatment will work best for different patient groups.

NDS Staff Awards presented at garden party

A number of staff from the Nuffield Department of Surgical Sciences (NDS) have been honoured at an annual awards ceremony.

New Associate Professors announced

The University of Oxford has announced the promotion to Associate Professor of two senior academics at the Nuffield Department of Surgical Sciences.

Blog posts

My virtual work experience with NDS and NDORMS

Louise Tan, a Year 12 student from Ballyclare in County Antrim, Northern Ireland, recently attended the joint NDS and NDORMS Virtual Work Experience. In this guest blog, Louise reflects on her experience.

Celebrating women of NDS

To celebrate 100 years since women were admitted as full members of the University and on the occasion of International Women's Day, a group of inspirational women in the Nuffield Department of Surgical Sciences (NDS) reflect on their journeys, their place in Medical Sciences and their vision for the next 100 years.

The life of a research nurse: supporting the Oxford COVID-19 Vaccine Trial

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

Why I became a Peer Supporter

The Peer Support Programme was developed in recognition of the essential role students play in supporting and encouraging one another on a day-to-day basis throughout their time at university. NDS’ own Helen Stark discusses her experience of becoming a Peer Supporter.

Racism under the microscope

As Black History Month gets underway in the UK, NDS Athena SWAN Coordinator Emily Hotine puts racism under the microscope.